ADAMH Q1 2026 Earnings Strong EPS Surprise Highlights Solid Underlying Performance Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses ANVS Q1 2026 Earnings WiderthanExpected Loss as Pipeline Progress Continues Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin UCTT Q1 2026 Earnings EPS Beats Estimates by 16 as Company Delivers Solid Performance SNFCA Q4 2025 Earnings Earnings per share of 053 reported stock edges lower